Literature DB >> 2014213

Relationship between drug absorption enhancing activity and membrane perturbing effects of acylcarnitines.

E L LeCluyse1, L E Appel, S C Sutton.   

Abstract

Acylcarnitines with chain lengths of 2 to 18 carbon atoms were tested for their effects on rat intestinal brush border membrane order (S) by fluorescence polarization of 1,6-diphenyl-1,3,5-hexatriene (DPH). These results were compared to the previously reported effectiveness of the acylcarnitines as absorption enhancers of the poorly absorbed antibiotic cefoxitin. Acylcarnitines with fatty acids less than 12 carbon units in length were ineffective in increasing drug absorption and perturbing brush border membrane order. Long-chain acylcarnitines (12-18 carbons) significantly increased the bioavailability of cefoxitin and decreased the lipid order of brush border membranes. The results suggest that, in order to promote drug absorption, the acylcarnitines must surpass a critical chain length (10 carbon units) to partition effectively into the membrane and, in addition, must perturb the lipid order beyond a threshold value (15-20%). Membrane perturbing capacity may serve as an indicator of the absorption enhancing potential of other aliphatic-type compounds.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014213     DOI: 10.1023/a:1015838508656

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Effect of chlorpromazine on the permeability of beta-lactam antibiotics across rat intestinal brush border membrane vesicles.

Authors:  K Iseki; M Sugawara; H Saitoh; K Miyazaki; T Arita
Journal:  J Pharm Pharmacol       Date:  1988-10       Impact factor: 3.765

Review 2.  Fluidity parameters of lipid regions determined by fluorescence polarization.

Authors:  M Shinitzky; Y Barenholz
Journal:  Biochim Biophys Acta       Date:  1978-12-15

3.  Effect of chain length in homologous series of anionic surfactants on irritant action and toxicity.

Authors:  H Schott
Journal:  J Pharm Sci       Date:  1973-02       Impact factor: 3.534

4.  The role of acyltransferases in fatty acid utilization.

Authors:  B Borrebaek; R Christiansen; B O Christophersen; J Bremer
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

5.  Effects of anesthetic alcohols on membrane transport processes in human erythrocytes.

Authors:  H Kutchai; L H Chandler; L M Geddis
Journal:  Biochim Biophys Acta       Date:  1980-08-14

6.  Effects of salicylic acid on the permeability of the plasma membrane of the small intestine of the rat: a fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption.

Authors:  H Kajii; T Horie; M Hayashi; S Awazu
Journal:  J Pharm Sci       Date:  1986-05       Impact factor: 3.534

7.  Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements.

Authors:  W J Van Blitterswijk; R P Van Hoeven; B W Van der Meer
Journal:  Biochim Biophys Acta       Date:  1981-06-22

Review 8.  Carnitine--metabolism and functions.

Authors:  J Bremer
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

9.  1-[4-(Trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers.

Authors:  F G Prendergast; R P Haugland; P J Callahan
Journal:  Biochemistry       Date:  1981-12-22       Impact factor: 3.162

10.  Fluorescence study on the interaction of salicylate with rat small intestinal epithelial cells: possible mechanism for the promoting effects of salicylate on drug absorption in vivo.

Authors:  H Kajii; T Horie; M Hayashi; S Awazu
Journal:  Life Sci       Date:  1985-08-12       Impact factor: 5.037

View more
  15 in total

Review 1.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers.

Authors:  Mikio Tomita; Nobuyuki Doi; Masahiro Hayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

3.  Nasal absorption kinetic behavior of azetirelin and its enhancement by acylcarnitines in rats.

Authors:  S Kagatani; N Inaba; M Fukui; T Sonobe
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

4.  Oleoyl-L-carnitine inhibits glycine transport by GlyT2.

Authors:  J E Carland; R E Mansfield; R M Ryan; R J Vandenberg
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Simultaneous in vitro measurement of intestinal tissue permeability and transepithelial electrical resistance (TEER) using Sweetana-Grass diffusion cells.

Authors:  S C Sutton; A E Forbes; R Cargill; J H Hochman; E L LeCluyse
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

6.  Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.

Authors:  S G Chandler; N W Thomas; L Illum
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

7.  Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies.

Authors:  T M Turunen; A Urtti; P Paronen; K L Audus; J H Rytting
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

8.  Lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro.

Authors:  P M Reardon; D A Wall; T K Hart; P L Smith; C H Gochoco
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

9.  Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.

Authors:  J L Richardson; L Illum; N W Thomas
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

10.  Oral delivery of a renin inhibitor compound using emulsion formulations.

Authors:  T T Kararli; T E Needham; M Griffin; G Schoenhard; L J Ferro; L Alcorn
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.